Get the Stockscreener App
14.81
2.31%
-0.35
Pre-market:
15.67
0.86
+5.81%
Arcutis Biotherapeutics Inc Stock (ARQT) Financials Data
Income Statement
Quarterly
*All numbers in millions
| Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
| Revenues |
266.47%
49.57
|
13.53 | 38.11 | 5.19 | 2.781 |
| Cost Of Revenue |
3.256
|
- | - | - | - |
| Gross Profit |
46.31
|
- | - | - | - |
Operating Expenses
|
11.80%
77.94
|
69.71 | 75.01 | 71.95 | 79.05 |
| Interest Income/Expense |
3.63%
7.48
|
7.762 | 7.559 | 7.349 | 7.042 |
| Benefits Costs and Expenses |
73.00%
81.19
|
300.71 | - | - | - |
| Costs And Expenses |
8.70%
81.19
|
74.69 | 75.01 | 71.95 | 79.05 |
| Operating Income/Loss |
48.30%
-31.62
|
-61.17 | -36.90 | -66.76 | -76.27 |
| Income/Loss From Continuing Operations Before Tax |
88.99%
-31.62
|
-287.18 | 38.11 | -70.99 | -80.10 |
| Income Tax Expense/Benefit |
1,196%
0.324
|
0.025 | 3.023 | - | - |
| Income/Loss From Continuing Operations After Tax |
46.62%
-35.38
|
-66.28 | -44.77 | -70.99 | -80.10 |
|
Net Income/Loss
|
46.62%
-35.38
|
-66.28 | -44.77 | -70.99 | -80.10 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1,316%
111.05
|
7.8435 | 61.73 | 61.43 | 61.17 |
| Diluted Average Shares |
1,316%
111.05
|
7.8435 | 61.73 | 61.43 | 61.17 |
| Basic Earnings Per Share |
45.76%
-0.32
|
-0.59 | -0.73 | -1.16 | -1.31 |
| Diluted Earnings Per Share |
45.76%
-0.32
|
-0.59 | -0.73 | -1.16 | -1.31 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.39%
0.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):